NDC 0378-5440 – Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate
Emtricitabine 200 mg/1; Rilpivirine Hydrochloride 25 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral
Product NDC0378-5440
Product details
- Brand name
- Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate
- Generic name
- Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA208452
- Marketed since
- May 27, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Emtricitabine 200 mg/1
- Rilpivirine Hydrochloride 25 mg/1
- Tenofovir Disoproxil Fumarate 300 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0378-5440-93 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5440-93) | May 27, 2025 |